Management of Acute Cholecystitis

Diagnostic Confirmation

Ultrasound is the first-line imaging modality, demonstrating gallstones, gallbladder wall thickening, pericholecystic fluid, and ultrasonographic Murphy's sign with 92-95% positive predictive value when combined with stones, according to the Clinical Infectious Diseases guidelines 4, 5
Hepatobiliary scintigraphy (HIDA scan) serves as the gold standard when ultrasound is inconclusive, with 80-90% sensitivity for cystic duct obstruction, as recommended by the Clinical Infectious Diseases guidelines 4, 5

The American College of Surgeons recommends first-line antibiotic therapy with Amoxicillin/clavulanate 2g/0.2g IV every 8 hours for stable, immunocompetent patients with community-acquired acute cholecystitis 3, 6
Alternative antibiotic regimens include Ceftriaxone plus metronidazole and Ticarcillin/clavulanate, as suggested by the Praxis Medical Insights guidelines 3
For critically ill or immunocompromised patients, the Praxis Medical Insights guidelines recommend Piperacillin/tazobactam 4g/0.5g IV every 6 hours or 16g/2g by continuous infusion 3, 6
Ertapenem 1g IV every 24 hours is recommended for patients at risk of ESBL-producing organisms, according to the Praxis Medical Insights guidelines 3

Early laparoscopic cholecystectomy within 72 hours of diagnosis is superior to delayed surgery, with possible extension up to 7-10 days from symptom onset, as recommended by the World Journal of Emergency Surgery guidelines 1, 2, 3
Laparoscopic cholecystectomy is the first-choice surgical approach when adequate resources and surgical expertise are available, according to the World Journal of Emergency Surgery guidelines 1, 2, 7
Risk factors predicting conversion to open cholecystectomy include age >65 years, male gender, acute cholecystitis, thickened gallbladder wall, diabetes mellitus, and previous upper abdominal surgery, as identified by the World Journal of Emergency Surgery guidelines 2

For uncomplicated cholecystitis with complete source control, no postoperative antibiotics are necessary, as recommended by the World Journal of Emergency Surgery and Praxis Medical Insights guidelines 2, 3, 6
For complicated cholecystitis with adequate source control in immunocompetent, non-critically ill patients, the Praxis Medical Insights guidelines recommend a maximum of 4 days of antibiotic therapy 3
For immunocompromised or critically ill patients, the Praxis Medical Insights guidelines recommend up to 7 days of antibiotic therapy 3

For patients with concomitant choledocholithiasis/cholangitis, the Praxis Medical Insights guidelines recommend MRCP to evaluate the common bile duct 6
ERCP is the treatment of choice for biliary decompression in moderate/severe acute cholangitis, as recommended by the World Journal of Emergency Surgery guidelines 1
Elderly patients with uncomplicated cholecystitis do not require postoperative antibiotics when source control is achieved, according to the Praxis Medical Insights guidelines 6